SCHEMBL5813745

SCHEMBL5813745

COc1ccccc1/C=C/CNc1cccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDKN1A P38936 1/20 0.57
PIM1 P11309 3/20 0.47
MAPK13 O15264 3/20 0.47
LIMK1 P53667 2/20 0.46
BRAF P15056 12/20 0.45
DAPK3 O43293 1/20 0.44
AKT1 P31749 1/20 0.44
MAPK9 P45984 1/20 0.44
GSK3A P49840 1/20 0.44
NEK2 P51955 1/20 0.44
PIM3 Q86V86 1/20 0.44
PLK3 Q9H4B4 1/20 0.44
MARK2 Q7KZI7 1/20 0.40
TLR8 Q9NR97 1/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5813753 1.00 CDKN1A (0.57) CDKN1APIM1MAPK13LIMK1BRAF
SCHEMBL5807911 0.88 CDKN1A (0.55) CDKN1APIM1MAPK13LIMK1BRAF
SCHEMBL5807917 0.88 CDKN1A (0.55) CDKN1APIM1MAPK13LIMK1BRAF
SCHEMBL5946559 0.88 CDKN1A (0.58) CDKN1APIM1MAPK13LIMK1BRAF
SCHEMBL5946562 0.88 CDKN1A (0.58) CDKN1APIM1MAPK13LIMK1BRAF
SCHEMBL5946522 0.87 CDKN1A (0.63) CDKN1APIM1MAPK13LIMK1BRAF
SCHEMBL5946521 0.87 CDKN1A (0.63) CDKN1APIM1MAPK13LIMK1BRAF
SCHEMBL5823565 0.87 CDKN1A (0.65) CDKN1APIM1MAPK13LIMK1BRAF
SCHEMBL5823567 0.87 CDKN1A (0.65) CDKN1APIM1MAPK13LIMK1BRAF
SCHEMBL5813348 0.86 CDKN1A (0.66) CDKN1APIM1MAPK13LIMK1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006033796-A1 SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME WYETH (US) 2006-03-30 WO claimed
US-20060063785-A1 Substituted pyrazolo[1,5-a] pyrimidines and process for making same WYETH 2006-03-23 US claimed
US-20060063784-A1 Method of using substituted pyrazolo [1,5-a] pyrimidines WYETH 2006-03-23 US disclosed
US-20060063785-A1 Substituted pyrazolo[1,5-a] pyrimidines and process for making same WYETH 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063785-A1 Substituted pyrazolo[1,5-a] pyrimidines and process for making same TYMP, DPYD, TYMS CDKN1A 28/4885PIM1 586/4885MAPK13 1171/4885
US-20060063784-A1 Method of using substituted pyrazolo [1,5-a] pyrimidines TYMP, DPYD, TYMS CDKN1A 89/4885PIM1 797/4885MAPK13 1727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.